Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 4420: Identification of a novel marker gene predicting recurrence after chemotherapy with DNA-damaging agents by using drug-resistant gastric cancer organoids

Kenji Harada, Naoya Sakamoto, Shingo Sakashita, Motohiro Kojima, Kazuaki Tanabe, Hideki Ohdan, Kohei Shitara, Takahiro Kinoshita, Genichiro Ishii, Wataru Yasui, Atsushi Ochiai, Shumpei Ishikawa

Cancer Res (2025) 85 (8_Supplement_1): 4420.

https://doi.org/10.1158/1538-7445.AM2025-4420

Published: 21 April 2025

View article titled, Abstract 4420: Identification of a novel marker gene predicting recurrence after chemotherapy with DNA-damaging agents by using drug-resistant gastric cancer organoids

Journal Articles

Abstract 1211: Biomarker analysis of pembrolizumab and ramucirumab neoadjuvant therapy for PD-L1-positive stage IB-IIIA lung cancer: EAST ENERGY trial

Kotaro Nomura, Shogo Kumagai, Shohei Koyama, Keiju Aokage, Yoshihisa Shimada, Kiyotaka Yoh, Masashi Wakabayashi, Miki Fukutani, Hideki Furuya, Tomohiro Miyoshi, Kenta Tane, Joji Samejima, Tetsuro Taki, Takuo Hayashi, Jun Matsubayashi, Genichiro Ishii, Norihiko Ikeda, Hiroyoshi Nishikawa, Masahiro Tsuboi

Cancer Res (2024) 84 (6_Supplement): 1211.

https://doi.org/10.1158/1538-7445.AM2024-1211

Published: 22 March 2024

View article titled, Abstract 1211: Biomarker analysis of pembrolizumab and ramucirumab neoadjuvant therapy for PD-L1-positive stage IB-IIIA lung cancer: EAST ENERGY trial

Journal Articles

Abstract 5185: First in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination

Cancer Res (2022) 82 (12_Supplement): 5185.

https://doi.org/10.1158/1538-7445.AM2022-5185

Published: 15 June 2022

View article titled, Abstract 5185: First in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination

Journal Articles

Abstract 6381: Superior effects of polymeric micelles in reprogramming tumor microenvironment and enhancing nano-immunotherapy

Myrofora Panagi, Fotios Mpekris, Pengwen Chen, Chrysovalantis Voutouri, Yasuhiro Nakagawa, John D. Martin, Tetsuro Hiroi, Hiroko Hashimoto, Genichiro Ishii, Motohiro Kojima, Kazunori Kataoka, Horacio Cabral, Triantafyllos Stylianopoulos

Cancer Res (2022) 82 (12_Supplement): 6381.

https://doi.org/10.1158/1538-7445.AM2022-6381

Published: 15 June 2022

View article titled, Abstract 6381: Superior effects of polymeric micelles in reprogramming tumor microenvironment and enhancing nano-immunotherapy

Journal Articles

Abstract 4919: Required numbers of biopsy samples and tumor cells for the assessment of PD-L1 expression to predict a response to nivolumab treatment in patients with NSCLC

Jun Sato, Tomoyuki Naito, Hibiki Udagawa, Hidehito Horinouchi, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe, Yoshitaka Zenke, Keisuke Kirita, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Noriko Motoi, Genichiro Ishii, Koichi Goto

Cancer Res (2019) 79 (13_Supplement): 4919.

https://doi.org/10.1158/1538-7445.AM2019-4919

Published: 01 July 2019

View article titled, Abstract 4919: Required numbers of biopsy samples and tumor cells for the assessment of PD-L1 expression to predict a response to nivolumab treatment in patients with NSCLC

Journal Articles

Abstract 4920: A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation

Tetsuya Sakai, Hibiki Udagawa, Yoshitaka Zenke, Keisuke Kirita, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Genichiro Ishii, Koichi Goto

Cancer Res (2019) 79 (13_Supplement): 4920.

https://doi.org/10.1158/1538-7445.AM2019-4920

Published: 01 July 2019

View article titled, Abstract 4920: A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation

Journal Articles

Abstract 918: A secondary RET mutation allosterically conferring resistance to vandetanib

Takashi Nakaoku, Takashi Kohno, Mitsugu Araki, Seiji Nino, Rakhee Chauhan, Phillip P. Knowles, Katsuya Tsuchihara, Shingo Matsumoto, Yoko Shimada, Sachiyo Mimaki, Genichiro Ishii, Hitoshi Ichikawa, Yasushi Okuno, Kiyotaka Yoh, Neil Q. McDonald, Koichi Goto

Cancer Res (2018) 78 (13_Supplement): 918.

https://doi.org/10.1158/1538-7445.AM2018-918

Published: 01 July 2018

View article titled, Abstract 918: A secondary RET mutation allosterically conferring resistance to vandetanib

Journal Articles

Abstract 3932: Metabolic biomarkers predict the sensitivity to phosphatidylinositol 3-kinase pathway inhibitor in small-cell lung carcinoma

Shigeki Umemura, Hideki Makinoshima, Genichiro Ishii, Takehiko Sasaki, Hiroyasu Esumi, Koichi Goto, Katsuya Tsuchihara

Cancer Res (2018) 78 (13_Supplement): 3932.

https://doi.org/10.1158/1538-7445.AM2018-3932

Published: 01 July 2018

View article titled, Abstract 3932: Metabolic biomarkers predict the sensitivity to phosphatidylinositol 3-kinase pathway inhibitor in small-cell lung carcinoma

Journal Articles

Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma

Hideki Makinoshima, Shigeki Umemura, Ayako Suzuki, Hiroki Nakanishi, Ami Maruyama, Hibiki Udagawa, Sachiyo Mimaki, Shingo Matsumoto, Seiji Niho, Genichiro Ishii, Masahiro Tsuboi, Atsushi Ochiai, Hiroyasu Esumi, Takehiko Sasaki, Koichi Goto, Katsuya Tsuchihara

Cancer Res (2018) 78 (9): 2179–2190.

https://doi.org/10.1158/0008-5472.CAN-17-2109

Published: 30 April 2018

View article titled, Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 5921: Microenvironmental changes in the progression from adenocarcinoma in situ to early-invasive adenocarcinoma of the lung

MASAHITO NAITO, Yukitoshi Satoh, Genichiro Ishii

Cancer Res (2017) 77 (13_Supplement): 5921.

https://doi.org/10.1158/1538-7445.AM2017-5921

Published: 01 July 2017

View article titled, Abstract 5921: Microenvironmental changes in the progression from adenocarcinoma in situ to early-invasive adenocarcinoma of the lung

Journal Articles

Abstract 5087: EMT in cancer cells promotes the extracellular matrix remodeling by cancer-associated fibroblasts

Shinya Neri, Genichiro Ishii, Atsushi Ochiai, Toshi Menju, Makoto Sonobe, Hiroshi Date

Cancer Res (2016) 76 (14_Supplement): 5087.

https://doi.org/10.1158/1538-7445.AM2016-5087

Published: 15 July 2016

View article titled, Abstract 5087: EMT in cancer cells promotes the extracellular matrix remodeling by cancer-associated fibroblasts

Journal Articles

Abstract 5004: Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: A comparative analysis with adenocarcinoma and squamous cell carcinoma

Yuki Matsumura, Shigeki Umemura, Genichiro Ishii, Koji Tsuta, Shingo Mastsumoto, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Yuichiro Ohe, Hiroyuki Suzuki, Atsushi Ochiai, Koichi Goto, Kanji Nagai, Katsuya Tsuchihara

Cancer Res (2015) 75 (15_Supplement): 5004.

https://doi.org/10.1158/1538-7445.AM2015-5004

Published: 01 August 2015

View article titled, Abstract 5004: Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: A comparative analysis with adenocarcinoma and squamous cell carcinoma

Journal Articles

Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression

Ayuko Hoshino, Genichiro Ishii, Takashi Ito, Kazuhiko Aoyagi, Yoichi Ohtaki, Kanji Nagai, Hiroki Sasaki, Atsushi Ochiai

Cancer Res (2011) 71 (14): 4769–4779.

https://doi.org/10.1158/0008-5472.CAN-10-3228

Published: 14 July 2011

View article titled, Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression

Includes: Supplementary data

Journal Articles

MMP-7 degrades soluble VEGFR-1 to release VEGF from the inhibitory complex.

Ta-Kashi Ito, Genichiro Ishii, Atsushi Ochiai

Cancer Res (2008) 68 (9_Supplement): 286.

Published: 01 May 2008

View article titled, MMP-7 degrades soluble VEGFR-1 to release VEGF from the inhibitory complex.

Journal Articles

Eg5 expression is closely correlated with response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy

Takamoto Saijo, Genichiro Ishii, Atsushi Ochiai, Kiyotaka Yoh, Koichi Gotoh, Kaoru Kubota, Kanji Nagai, Yutaka Nishiwaki, Nagahiro Saijo

Cancer Res (2006) 66 (8_Supplement): 1065.

Published: 15 April 2006

View article titled, Eg5 expression is closely correlated with response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy

Journal Articles

Chemopreventive Effect of Peroxisome Proliferator–Activated Receptor γ on Gastric Carcinogenesis in Mice

Jie Lu, Kazuhiro Imamura, Sachiyo Nomura, Ken-ichi Mafune, Atsushi Nakajima, Takashi Kadowaki, Naoto Kubota, Yasuo Terauchi, Genichiro Ishii, Atsushi Ochiai, Hiroyasu Esumi, Michio Kaminishi

Cancer Res (2005) 65 (11): 4769–4774.

https://doi.org/10.1158/0008-5472.CAN-04-2293

Published: 01 June 2005

View article titled, Chemopreventive Effect of Peroxisome Proliferator–Activated Receptor γ on Gastric Carcinogenesis in Mice

Journal Articles

Growth Inhibition of Human Prostate Cancer Cells in Human Adult Bone Implanted into Nonobese Diabetic/Severe Combined Immunodeficient Mice by a Ligand-Specific Antibody to Human Insulin-Like Growth Factors

Masato Goya, Shin’ichi Miyamoto, Kanji Nagai, Yuji Ohki, Kazuyasu Nakamura, Kenya Shitara, Hiroyuki Maeda, Takafumi Sangai, Keiji Kodama, Yasushi Endoh, Genichiro Ishii, Takahiro Hasebe, Hiroyuki Yonou, Tadashi Hatano, Yoshihide Ogawa, Atsushi Ochiai

Cancer Res (2004) 64 (17): 6252–6258.

https://doi.org/10.1158/0008-5472.CAN-04-0919

Published: 01 September 2004

View article titled, Growth Inhibition of Human Prostate Cancer Cells in Human Adult Bone Implanted into Nonobese Diabetic/Severe Combined Immunodeficient Mice by a Ligand-Specific Antibody to Human Insulin-Like Growth Factors

Journal Articles

Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3

Shin’ichi Miyamoto, Keiichi Yano, Seiji Sugimoto, Genichiro Ishii, Takahiro Hasebe, Yasushi Endoh, Keiji Kodama, Masato Goya, Tsutomu Chiba, Atsushi Ochiai

Cancer Res (2004) 64 (2): 665–671.

https://doi.org/10.1158/0008-5472.CAN-03-1916

Published: 26 January 2004

View article titled, Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 4420: Identification of a novel marker gene predicting recurrence after chemotherapy with DNA-damaging agents by using drug-resistant gastric cancer organoids

Abstract 1211: Biomarker analysis of pembrolizumab and ramucirumab neoadjuvant therapy for PD-L1-positive stage IB-IIIA lung cancer: EAST ENERGY trial

Abstract 5185: First in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination

Abstract 6381: Superior effects of polymeric micelles in reprogramming tumor microenvironment and enhancing nano-immunotherapy

Abstract 4919: Required numbers of biopsy samples and tumor cells for the assessment of PD-L1 expression to predict a response to nivolumab treatment in patients with NSCLC

Abstract 4920: A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation

Abstract 918: A secondary RET mutation allosterically conferring resistance to vandetanib

Abstract 3932: Metabolic biomarkers predict the sensitivity to phosphatidylinositol 3-kinase pathway inhibitor in small-cell lung carcinoma

Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma

Abstract 5921: Microenvironmental changes in the progression from adenocarcinoma in situ to early-invasive adenocarcinoma of the lung

Abstract 5087: EMT in cancer cells promotes the extracellular matrix remodeling by cancer-associated fibroblasts

Abstract 5004: Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: A comparative analysis with adenocarcinoma and squamous cell carcinoma

Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression

MMP-7 degrades soluble VEGFR-1 to release VEGF from the inhibitory complex.

Eg5 expression is closely correlated with response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy

Chemopreventive Effect of Peroxisome Proliferator–Activated Receptor γ on Gastric Carcinogenesis in Mice

Growth Inhibition of Human Prostate Cancer Cells in Human Adult Bone Implanted into Nonobese Diabetic/Severe Combined Immunodeficient Mice by a Ligand-Specific Antibody to Human Insulin-Like Growth Factors

Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media